FourWorld Capital Management LLC reduced its position in shares of Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 18.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,090,851 shares of the biopharmaceutical company’s stock after selling 251,056 shares during the quarter. Arbutus Biopharma […]
Clear Harbor Asset Management LLC grew its position in Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 148.6% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 131,761 shares of the biopharmaceutical company’s stock after purchasing an additional 78,761 shares during the period. Clear Harbor Asset Management LLC’s holdings in Arbutus Biopharma were worth […]
StockNews.com started coverage on shares of Arbutus Biopharma (NASDAQ:ABUS – Free Report) in a research report released on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the stock. HC Wainwright reiterated a buy rating and set a $6.00 target price on shares […]
Arbutus Biopharma (NASDAQ:ABUS) Receives New Coverage from Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Arbutus Biopharma s (ABUS) Buy Rating Reiterated at Chardan Capital themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.